Using Human Stem Cells to Improve Blood Flow in Ischemic Limbs
Author Information
Author(s): Yamahara Kenichi, Sone Masakatsu, Itoh Hiroshi, Yamashita Jun K., Yurugi-Kobayashi Takami, Homma Koichiro, Chao Ting-Hsing, Miyashita Kazutoshi, Park Kwijun, Oyamada Naofumi, Sawada Naoya, Taura Daisuke, Fukunaga Yasutomo, Tamura Naohisa, Nakao Kazuwa
Primary Institution: Kyoto University Graduate School of Medicine
Hypothesis
Can combined transplantation of human embryonic stem cell-derived endothelial and mural cells enhance vascular regeneration in hindlimb ischemia?
Conclusion
The combined transplantation of human embryonic stem cell-derived endothelial and mural cells significantly improves blood flow recovery in ischemic limbs.
Supporting Evidence
- Transplanted human VPC-derived cells significantly improved blood flow recovery in ischemic limbs compared to control groups.
- Capillary density was significantly higher in the group receiving combined EC and MC transplants.
- Human VPC-derived cells were effectively incorporated into host blood vessels.
Takeaway
Scientists found that using special cells from human embryos can help heal damaged blood vessels in the legs, making them work better again.
Methodology
Human embryonic stem cell-derived vascular cells were transplanted into mice with hindlimb ischemia to assess blood flow recovery and capillary density.
Potential Biases
Potential bias in cell selection and transplantation methods.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
Nude mice were used for the experiments.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website